VolitionRx Ltd. History - Founding, Milestones & Growth Journey

History

Year	Detail
2010	Jake Micallef, Mark Eccleston, and Cameron Reynolds co-founded Volition to make cancer diagnostics more accessible and less invasive.
2022	The company signed an exclusive $28 million license and supply agreement with Heska Corp. to sell its Nu.Q Vet Cancer Screening Test at the point of care for companion animals.
2023	The company partnered with Veterinary Pathology Group (VPG), the UK’s diagnostic laboratories, to launch the Nu.Q Vet Cancer Test to veterinary practices in the U.K. and Ireland.
2024	The company partnered with Fujifilm Vet Systems Co. Ltd, a veterinary diagnostic laboratory service, to launch the Nu. Q Vet Cancer Test to veterinarians in Japan.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.